You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable Head and Neck Squamous Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Penpulimab injection
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
Oct 7, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2023

Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Locally Advanced Operable
  • Guangzhou, Guangdong, China
  • +1 more
Sep 4, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab paclitaxel
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Oral Cancer
  • Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun yat-sun memorial hospital
Jul 10, 2023

Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinomas
  • Tislelizumab + Dasatinib + Quercetin
  • surgery
  • (no location specified)
Feb 2, 2023

Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,

Active, not recruiting
  • Cancer of Head and Neck
  • +5 more
  • MK-3475 (neoadjuvant)
  • +6 more
  • Boston, Massachusetts
  • +2 more
Dec 9, 2022

Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Toripalimab+cetuximab)

Recruiting
  • Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Nov 1, 2022

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Head and Neck Squamous Cell Carcinomas Trial in Guanzhou (drug, procedure, radiation)

Recruiting
  • Head and Neck Squamous Cell Carcinomas
  • Guanzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 28, 2022

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy

Suspended
  • Resectable Head and Neck Squamous Cell Carcinoma
  • 42 Gy Radiation Therapy
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jan 13, 2023

Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Liuxiqiang
Feb 1, 2023

Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
  • (no location specified)
Nov 11, 2023

Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab plus TP, TP)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Camrelizumab plus TP
  • TP
  • Wuhan, Hubei, China
    Hospital of Stomatology, Wuhan University
Mar 22, 2023

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Dec 7, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • External Beam Radiation Therapy
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in United Kingdom (NG-641, Pembrolizumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • NG-641
  • Pembrolizumab
  • Cardiff, United Kingdom
  • +3 more
Jun 23, 2022

Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

Completed
  • Oral Cancer
  • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital
Nov 20, 2023

Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab Combined With Neoadjuvant Chemotherapy)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nimotuzumab Combined With Neoadjuvant Chemotherapy
  • (no location specified)
Jun 29, 2022

Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 23, 2022

Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Jan 19, 2023